View clinical trials related to Migraine Headache.
Filter by:This study evaluates the non-inferiority of Cefaliv® compared to Neosaldina® in the treatment of migraine attack in two hundred and sixteen adults of both sexes with age between eighteen and sixty five years old. The first Half of participants will receive Cefaliv®, the other half will receive Neosaldina®.
The purpose of this study is to determine the effects of triptans and doxycycline on neuroinflammatory markers in acute migraine.